Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling

Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is considered to be dependent on PI3Kα. We used mice lacking p110α, the catalytic subunit of PI3Kα, to investigate its role in the regulation of liver gene expression in health and in metabolic dysfunction-associated steatotic liver disease (MASLD). The absence of hepatocyte PI3Kα reduced maximal insulin-induced PI3K activity and signaling, promoted glucose intolerance in lean mice and significantly regulated liver gene expression, including insulin-sensitive genes, in ad libitum feeding. Some of the defective regulation of gene expression in response to hepatocyte-restricted insulin receptor deletion was related to PI3Kα signaling. In addition, though PI3Kα deletion in hepatocytes promoted insulin resistance, it was protective against steatotic liver disease in diet-induced obesity. In the absence of hepatocyte PI3Kα, the effect of diet-induced obesity on liver gene expression was significantly altered, with changes in rhythmic gene expression in liver. Altogether, this study highlights the specific role of p110α in the control of liver gene expression in physiology and in the metabolic rewiring that occurs during MASLD.

Authors

Institutions

Publication Details

Journal
PLoS Biology
Published
2025-04-14
DOI
https://doi.org/10.1371/journal.pbio.3003112
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling

Sandrine Ellero‐Simatos, Walter Wahli, Marion Régnier, Sarra Smati et al.
1 citations
PLoS Biology
Liver Disease Diagnosis and Treatment
1.35
article

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling

Sandrine Ellero‐Simatos, Walter Wahli, Marion Régnier, Sarra Smati, Anne Fougerat, Laurent Debrauwer, Céline Lukowicz, Len Stephens, Phillip T. Hawkins, Alexandra Montagner, Julie Guillermet‐Guibert, Laurence Gamet‐Payrastre, Prunelle Perrier, Rémy Burcelin, Frédèric Lasserre, Pierre Gourdy, Arnaud Polizzi, Justine Bertrand‐Michel, Catherine Postic, Clémence Rives, Blandine Tramunt, Claire Naylies, Yannick Lippi, Karen E. Anderson, Thierry Levade, Edwin Fouché, Cécile Canlet, Christophe Heymes, Tiffany Fougeray, Marine Huillet, Hervé Guillou, Elodie Rousseau-Bacquié, Nicolas Loiseau, Yuna Blum, Sylvie Chevolleau-Mege, Géraldine Garcia
article en
1 citations

Abstract

Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is considered to be dependent on PI3Kα. We used mice lacking p110α, the catalytic subunit of PI3Kα, to investigate its role in the regulation of liver gene expression in health and in metabolic dysfunction-associated steatotic liver disease (MASLD). The absence of hepatocyte PI3Kα reduced maximal insulin-induced PI3K activity and signaling, promoted glucose intolerance in lean mice and significantly regulated liver gene expression, including insulin-sensitive genes, in ad libitum feeding. Some of the defective regulation of gene expression in response to hepatocyte-restricted insulin receptor deletion was related to PI3Kα signaling. In addition, though PI3Kα deletion in hepatocytes promoted insulin resistance, it was protective against steatotic liver disease in diet-induced obesity. In the absence of hepatocyte PI3Kα, the effect of diet-induced obesity on liver gene expression was significantly altered, with changes in rhythmic gene expression in liver. Altogether, this study highlights the specific role of p110α in the control of liver gene expression in physiology and in the metabolic rewiring that occurs during MASLD.

PLoS BiologyVol. 23(4)
Centre National de la Recherche Scientifique (FR), Babraham Institute (GB), Inserm (FR), Nanyang Technological University (SG), École Nationale Vétérinaire de Toulouse (FR), Université Paris Cité (FR), Centre Hospitalier Universitaire de Toulouse (FR), Centre de Recherches en Cancérologie de Toulouse (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Toxicologie Alimentaire (FR), Institut de génétique et de développement de Rennes (FR), Institut Cochin (FR), Institut des Maladies Métaboliques et Cardiovasculaires (FR), Université de Rennes (FR), University of Lausanne (CH)
Agence Nationale de la Recherche, École Polytechnique Fédérale de Lausanne, Fondation pour la Recherche Médicale, Fondation de France, Université de Toulouse, Institut National Du Cancer, Région Occitanie Pyrénées-Méditerranée, AgreenSkills
Good health and well-being
Openalex Percentile: Top 21%
Liver Disease Diagnosis and Treatment
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.